Wellington Management
http://www.wellington.comWellington Management is an independent investment management company. The firm invests in a broad range of asset classes including global equity, fixed income, currency and commodity markets, including multi-strategy, specialty and alternative investment approaches.
View Older Stories View More Recent Stories
-
Vanguard's First Actively Managed ESG Fund Now Available For Investment
-
Stephen C. Concannon, CFA, and Jeffrey D. Mueller appointed Co-Directors of Eaton Vance Management High Yield Investments; Michael W. Weilheimer, CFA, to retire in January 2020
-
Form 13F-HR WELLINGTON MANAGEMENT For: Mar 31
-
Away is Valued at $1.4 Billion After a Series D Investment of $100 Million
-
Form SC 13G BRISTOL MYERS SQUIBB CO Filed by: WELLINGTON MANAGEMENT GROUP LLP
-
Form SC 13G Brigham Minerals, Inc. Filed by: WELLINGTON MANAGEMENT GROUP LLP
-
Form SC 13G/A CROWN CRAFTS INC Filed by: WELLINGTON MANAGEMENT GROUP LLP
-
Form SC 13G/A ProPetro Holding Corp. Filed by: WELLINGTON MANAGEMENT GROUP LLP
-
Form SC 13G/A Wayfair Inc. Filed by: WELLINGTON MANAGEMENT GROUP LLP
-
Form SC 13G Pinterest, Inc. Filed by: WELLINGTON MANAGEMENT GROUP LLP
-
Satsuma Pharmaceuticals Raises $62 Million in Series B Preferred Stock Financing
-
Payfone Raises $24 Million; Announces Strategic Partnership with TransUnion to Add Security, Convenience, and Privacy to Digital Experiences Around the Globe
-
PlacementTracker Publishes Q1 2019 PIPE and Private Placement Markets League Tables
-
Bristol-Myers says shareholders vote to approve Celgene takeover
-
Form SC 13G/A Nightstar Therapeutics Filed by: WELLINGTON MANAGEMENT GROUP LLP
-
Form SC 13G/A CHICOS FAS INC Filed by: WELLINGTON MANAGEMENT GROUP LLP
-
Form SC 13G/A ZUORA INC Filed by: WELLINGTON MANAGEMENT GROUP LLP
-
Form SC 13G/A GreenSky, Inc. Filed by: WELLINGTON MANAGEMENT GROUP LLP
-
MIT Sloan to hold "Finance Beyond Crisis" conference
-
Affirm Announces Series F Round of Equity Funding, Led by Thrive Capital
-
John Hancock Hedged Equity & Income Fund Required Notice To Shareholders - Sources Of Distribution Under Section 19(a)
-
Starboard abandons campaign to scuttle Bristol-Myers-Celgene deal
-
Whitehead Institute's David C. Page to Conclude Term as Director
-
Mutual funds start to put their mouth where their money is
-
Toll Brothers (TOL) Reports Election of Karen H. Grimes to Board
-
Karen H. Grimes Elected to Toll Brothers’ Board of Directors
-
Form SC 13G/A HAEMONETICS CORP Filed by: WELLINGTON MANAGEMENT GROUP LLP
-
Form SC 13G/A Post Holdings, Inc. Filed by: WELLINGTON MANAGEMENT GROUP LLP
-
Form SC 13G/A Spark Therapeutics, Inc. Filed by: WELLINGTON MANAGEMENT GROUP LLP
-
Form SC 13G/A NUVASIVE INC Filed by: WELLINGTON MANAGEMENT GROUP LLP
-
Form SC 13G/A ALDER BIOPHARMACEUTICALS Filed by: WELLINGTON MANAGEMENT GROUP LLP
-
Form SC 13G/A HMS HOLDINGS CORP Filed by: WELLINGTON MANAGEMENT GROUP LLP
-
Agenda Announced for Morningstar Investment Conference, the Industry's Largest Independent Conference
-
Girls Who Invest Celebrates International Women’s Day
-
CORRECTING and REPLACING Girls Who Invest Celebrates International Women’s Day
-
Vanguard Files For Its First Actively Managed ESG Fund
-
Bristol-Myers defends Celgene bet as investor criticism grows
-
Hartford Funds Expands Fixed Income Lineup with Securitized Income Fund
-
Holding(s) in Company
-
Intellia CEO not involved in Starboard's Bristol-Myers board challenge
-
Pre-Open Stock Movers 02/28: (SQBG) (TTOO) (WBC) Higher; (NVAX) (SYNH) (BOX) Lower (more...)
-
Starboard joins opposition to Bristol-Myers' $74 billion Celgene deal
-
Celgene (CELG) implied volatility into Wellington says it does not support Bristol-Myers' acquisition of Celgene
-
Bristol-Myers Squibb (BMY) IV into Wellington says it does not support Bristol-Myers' acquisition of Celgene (CELG)
-
After-Hours Movers 02/27: (TTOO) (TWNK) (WBC) Higher; (BOX) (BKNG) (CELG) (more...)
-
Form SC 13D BRISTOL MYERS SQUIBB CO Filed by: WELLINGTON MANAGEMENT GROUP LLP
-
Wellington Management Says it Does Not Support Bristol-Myers Squibb's (BMY) Acquisition of Celgene (CELG)
-
Wellington Management Does Not Support Bristol-Myers Squibb’s Acquisition of Celgene Corporation
-
Form X-17A-5 WELLINGTON MANAGEMENT For: Dec 31
-
John Hancock Hedged Equity & Income Fund Portfolio Management Update

